Mallinckrodt Plc (NYSE:MNK)

119.46
Delayed Data
As of Jul 02
 -0.81 / -0.67%
Today’s Change
67.18
Today|||52-Week Range
134.26
+20.63%
Year-to-Date

Today’s Trading

Previous close120.27
Today’s open120.68
Day’s range118.37 - 120.69
Volume1,030,142
Average volume (3 months)1,200,411
Market cap$13.8B
Dividend yield--
Data as of 4:03pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+48.81%
Earnings growth (next 5 years)+18.74%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc+0.06+0.07%
ENDPEndo International P...+1.13+1.40%
JAZZJazz Pharmaceuticals...+0.24+0.14%
ALKSAlkermes Plc-1.70-2.62%
Data as of 4:03pm ET, 07/02/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)$1.81
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers